Form 4: BioCardia CEO Boosts Stake with Open Market Purchases

Peter Altman, BioCardia's President and CEO, increased his direct ownership in the company by acquiring 1,100 shares of common stock over two days.

Summary

• Peter Altman, President and CEO, and a Director of BioCardia, Inc. (BCDA), acquired common stock.
• On December 16, 2025, Altman purchased 200 shares of common stock at a weighted average price of $1.37 per share.
• On December 17, 2025, Altman purchased an additional 900 shares of common stock at a weighted average price of $1.30 per share.
• These transactions were executed pursuant to a Rule 10b5-1(c) plan.
• Following these transactions, Altman directly beneficially owns 267,966 shares of BioCardia common stock.

Sentiment

Score: 8

Explanation: The direct purchase of company stock by the President and CEO, especially under a Rule 10b5-1 plan, is a strong positive signal of management's confidence in the company's future prospects and current valuation.

Positives

• Insider buying by the President and CEO signals confidence in the company's future prospects.
• The transactions were conducted under a Rule 10b5-1 plan, indicating a pre-arranged, non-opportunistic purchase.
• Increased direct ownership by a key executive aligns management's interests with those of shareholders.

Management Comments

• The act of purchasing shares by the President and CEO can be interpreted as a strong vote of confidence in the company's valuation and future performance.

Industry Context

Insider purchases, especially by top executives, are often viewed by the market as a positive indicator, suggesting that those with the most intimate knowledge of the company believe its stock is undervalued or poised for growth. This action by BioCardia's CEO could be seen as a signal of internal optimism, potentially contrasting with broader market sentiment or specific industry challenges if they exist.

Corporate Governance

Stakeholder Impact

• Shareholders: Positive, as insider buying often signals management's belief in future stock appreciation, potentially boosting investor confidence.
• Employees: May view the CEO's purchase as a sign of stability and positive outlook for the company.

Key Dates

Recommendation

The direct purchase of company stock by the President and CEO, Peter Altman, is a strong indicator of insider confidence. Executives typically have the most comprehensive understanding of their company's intrinsic value and future prospects. Such an action, especially when executed under a Rule 10b5-1 plan, suggests a belief that the stock is currently undervalued or poised for positive performance. This insider buying provides a compelling signal for investors to consider a "buy" recommendation, aligning with management's demonstrated conviction.

Keywords

BioCardia, BCDA, Insider Trading, Stock Purchase, CEO, Director, Form 4, Peter Altman, Equity Acquisition, Rule 10b5-1